Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Leukemia 3Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Hodgkin Disease 2Graft vs Host Disease 2Recurrence 1Primary Myelofibrosis 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Kidney Neoplasms 1Histiocytosis 1Hemoglobinuria, Paroxysmal 1Hemoglobinuria 1

Interventions

Radiotherapy 3Temozolomide 2Tamoxifen 2Magnetic Resonance Spectroscopy 2sargramostim 1aldesleukin 1Topotecan 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Muromonab-CD3 1Modafinil 1Mental Status and Dementia Tests 1Lapatinib 1Immunologic Techniques 1Immunoenzyme Techniques 1Imatinib Mesylate 1Ginkgo biloba extract 1Gefitinib 1FANG vaccine 1Drug Therapy 1Doxorubicin 1Donepezil 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Glioma, Subependymal × Muromonab-CD3 × Clear all
NCT00004024 2013-04-05

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
60 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡